Page last updated: 2024-08-16

resveratrol and navitoclax

resveratrol has been researched along with navitoclax in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Eguchi, H; Hayashi, SI; Ichihara, S; Sakamoto, T; Sasaki, S; Tanimoto, K; Tsuboi, K	1

Other Studies

1 other study(ies) available for resveratrol and navitoclax

Article	Year
Resveratrol exhibits diverse anti-cancer activities through epigenetic regulation of E-cadherin and p21 in triple-negative breast cancer cells. Breast cancer (Tokyo, Japan), 2023, Volume: 30, Issue:5 Topics: Antineoplastic Agents; Apoptosis; BRCA1 Protein; BRCA2 Protein; Cadherins; Cell Line, Tumor; Cell Proliferation; Epigenesis, Genetic; Histones; Humans; Resveratrol; Triple Negative Breast Neoplasms	2023

Article

Year

Resveratrol exhibits diverse anti-cancer activities through epigenetic regulation of E-cadherin and p21 in triple-negative breast cancer cells.

Breast cancer (Tokyo, Japan), 2023, Volume: 30, Issue:5

Topics: Antineoplastic Agents; Apoptosis; BRCA1 Protein; BRCA2 Protein; Cadherins; Cell Line, Tumor; Cell Proliferation; Epigenesis, Genetic; Histones; Humans; Resveratrol; Triple Negative Breast Neoplasms

2023